Mode
Text Size
Log in / Sign up

Frailty associated with higher odds of cognitive impairment in patients with chronic kidney diseaseFrailty increases risk of cognitive issues in kidney disease patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that frailty is associated with significantly higher odds of cognitive impairment in patients with chronic kidney disease.

This meta-analysis evaluated the relationship between frailty and cognitive outcomes in a large cohort of patients with chronic kidney disease (CKD). The study included a total sample size of 129,868 patients. The primary objective was to determine if frailty status serves as a significant indicator for cognitive impairment among those living with CKD.

The analysis compared patients identified as having frailty against a comparator group of robust patients. While specific dosing or intervention protocols were not applicable to this observational meta-analysis, the distinction between frailty and robustness served as the primary exposure variable for assessing cognitive outcomes in the CKD population.

The primary outcome was the presence of cognitive impairment. The results indicated that patients with frailty had higher odds of cognitive impairment compared to robust patients. Specifically, the analysis reported an odds ratio of 3.13 (95% CI 1.92-5.12). This finding indicates a substantial association between frailty and diminished cognitive function in the studied CKD population.

Secondary outcomes were not reported for this specific meta-analysis. The study focused primarily on the correlation between physical/functional frailty and cognitive status to identify high-risk subgroups within the chronic kidney disease demographic.

Safety and tolerability data, including adverse event rates or discontinuation rates, were not reported as the study design was a meta-analysis of observational data rather than a clinical trial. The focus remained on the association between pre-existing conditions (frailty) and outcomes (cognitive impairment).

These results contribute to the understanding of multi-morbidity in renal patients. While previous evidence has highlighted inflammation and immune dysregulation as central drivers of tissue remodeling and progression in CKD, this study specifically highlights frailty as a significant correlate for cognitive decline. The findings suggest that clinical management of CKD may need to incorporate geriatric assessments.

Several methodological limitations were identified. Heterogeneity in the association size was influenced by several factors including study region, specific frailty measurement methods, and various covariate adjustments (all p < 0.05). These variations suggest that the strength of the link between frailty and cognitive impairment may vary depending on how frailty is defined and measured in different clinical settings.

The results have significant implications for clinical practice. The findings highlight the importance of implementing targeted interventions, particularly for nonfrail CKD patients, to reduce the burden of cognitive impairment and improve overall patient outcomes. Identifying these patients early may allow for more proactive management of cognitive health.

Several questions remain unanswered regarding the underlying mechanisms driving this association. It is not yet clear if frailty directly causes cognitive decline or if both are driven by common underlying factors such as systemic inflammation or advanced age. Furthermore, the specific interventions that could most effectively mitigate these risks in nonfrail patients have not been established.

How this fits prior evidence

How this fits prior evidence This finding addresses a gap in the management of comorbidities in chronic kidney disease. While previous evidence identified inflammation and immune dysregulation as central drivers of tissue remodeling and progression in CKD, this meta-analysis adds a specific focus on frailty as a predictor for cognitive impairment. It complements existing knowledge by highlighting how physical status impacts neurological outcomes in the CKD population.

Living with chronic kidney disease (CKD) is a long journey that can affect many parts of your daily life. One of the most important aspects of staying independent as you age is your ability to think clearly, remember things, and process information. For people managing kidney issues, there is a growing concern about how their physical strength and overall health might impact their brain health over time.

To better understand this link, researchers looked at data from a very large group of over 129,000 patients with chronic kidney disease. They wanted to see if "frailty" played a role in mental clarity. Frailty is a term used to describe a state of increased vulnerability, often involving a loss of muscle strength, slower walking speed, and a general decline in physical stamina. The researchers compared these frail patients against those who were considered robust, meaning they were physically stronger and more resilient.

The results showed a clear connection between physical frailty and brain health. Patients with kidney disease who were identified as frail had much higher odds of experiencing cognitive impairment—which is the medical term for problems with memory or thinking—compared to their robust peers. Specifically, the data showed that these patients were over three times more likely to experience these mental challenges. This suggests that physical health and brain health are closely linked in people managing kidney disease.

While these findings are important, it is vital to remember that this study shows an association, not a cause. This means that while frailty and memory issues often happen together, we cannot say for certain that one directly causes the other based on this data alone. Additionally, because different regions and different ways of measuring frailty were involved, the results can vary depending on where a patient lives or how they are tested. For patients right now, these findings do not mean that a diagnosis of frailty is a guarantee of future memory loss. Instead, it highlights why staying active and maintaining physical strength is so important for people with kidney disease. By focusing on staying strong and mobile early on, patients may be better able to protect their cognitive health as they age. It serves as a call for doctors and patients to look at the whole person, ensuring that physical fitness is treated as a key part of managing kidney health.

What this means for you:
Patients with kidney disease who experience frailty are much more likely to have issues with memory or thinking.

Study Details

Study typeMeta analysis
Sample sizen = 129,868
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BACKGROUND: The literature has reported conflicting findings regarding the association between frailty and cognitive impairment in patients with chronic kidney disease (CKD). This systematic review and meta-analysis examined the association between frailty and cognitive impairment in patients with CKD. METHODS: A comprehensive search of Embase, PubMed, Scopus, Web of Science, CINAHL, and the Cochrane Central Register of Controlled Trials was conducted from database inception to February 2026. Eligible studies comprised cross-sectional, cohort, case-control, randomized controlled trials, and quasi-experimental studies that reported associations between frailty and cognitive impairment in patients with CKD, with no time or language restrictions. RESULTS: A total of 17 studies (9 cross-sectional and 8 cohort) involving 129,868 patients with CKD (mean age 60.88 years) were included in the meta-analysis. The findings indicated that patients with frailty with CKD had significantly higher odds of cognitive impairment than robust patients (odds ratio = 3.13, 95% CI 1.92-5.12). Heterogeneity in association size was influenced by study region, frailty measurement methods, and whether covariate adjustments were made during data analysis (all p < 0.05). CONCLUSIONS: This systematic review and meta-analysis identified a significant association between frailty and cognitive impairment in patients with CKD. Future prospective cohort studies should assess the causal relationships between frailty and cognitive impairment in this population. CLINICAL RELEVANCE STATEMENT: This study systematically assessed the association between frailty and cognitive impairment in patients with CKD, addressing inconsistent findings in prior research. The results highlight the importance of implementing targeted interventions, particularly for nonfrail CKD patients, to reduce the burden of cognitive impairment and improve patients' outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.